Sleep Clinic Management

Type I, II, III Clinical Precision, Anywhere.

Book A Demo

Clinical Precision, Anywhere

Bridge the gap between in-lab reliability and home-based accessibility. Traditional sleep lab expansion is limited by physical real estate, high staffing costs, and the logistical friction of in-lab PSG. DormoVision X™ redefines clinic management by offering a decentralized Type II polysomnography solution that scales with your patient volume. Validated at 96.6% equivalence to in-lab PSG, it allows you to offer gold-standard diagnostic depth in a portable format. Expand your diagnostic reach, reduce wait times, and optimize your clinical workflow with a 38-channel system designed for seamless laboratory integration.

Key Benefits

High-Fidelity Signal Integrity (38-Channel Suite)
Captures 29 direct physiological channels and 9 derived signals, including a full neurophysiological suite (6-channel EEG, EOG, Chin/Leg EMG).
Move beyond “estimated” metrics. Calculate actual Total Sleep Time (TST) and identify complex pathologies—such as REM-related disorders and periodic limb movements—that standard Type III HSATs miss.

Proven Diagnostic Alignment
The Data: Achieved a Cohen’s Kappa of 0.97 for severity classification and a mean AHI difference of only $-0.19$ events/h (p=0.7) compared to in-lab PSG.
Prescribe with total confidence. The 96.6% equivalence ensures that severity grading (Normal through Severe) remains consistent regardless of the testing environment.

Optimized Ecological Validity
Wireless, mask-integrated architecture eliminates nasal cannulas and intrusive leads, resulting in a 4.2/5 patient comfort rating.
Mitigate the “First-Night Effect.” By recording in the patient’s natural sleep environment without physical constraints, you capture representative, high-quality data with significantly reduced study failure rates.

Features

    • One Platform, Full PSG Capability At Home or In-Lab.
    • Wireless, Remote, And FDA-Cleared.
    • 38 Total Channels For Comprehensive Sleep Data.
    • Faster Diagnoses with Greater Clinical Confidence.
    • Expand Capacity, Reduce Costs, No Added Overhead.
    • Patient-Friendly Solution for Diagnosing Complex Sleep Disorders in Children

     

    Validated via NCT06224972 (N=47)

    • Nox A1 Comparison: Virtually identical mean AHI values recorded head-to-head.

    • Severity Match: Near-perfect alignment in distinguishing mild, moderate, and severe OSA cases.

    • Signal Reliability: Strong correlations across all secondary sleep parameters with minimal variance.

Keep up to date with our latest news and announcements!

Sign up with Dormotech to stay up to date on upcoming events, releases, and new research.